Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Belinda Jim |
Contact phone | 718-918-5762 |
Contact email | belinda_bun_jim@yahoo.com |
Dua signed dt | Aug. 17, 2009, midnight |
Site approved dt | Dec. 17, 2008, midnight |
Niddk signed dt | Aug. 20, 2009, midnight |